Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer
June 16, 2025
June 16, 2025
June 11, 2025
May 7, 2025
April 24, 2025
April 8, 2025
April 3, 2025
March 11, 2025
February 13, 2025
February 13, 2025
June 16, 2025
Fast Track granted for a next-generation, PARP1-selective inhibitor with CNS activity Addresses brain metastases harboring BRCA1/2 and/or HRR alterati...
June 11, 2025
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data Ceryx Medical, a UK-based medtech innovator develo...
May 7, 2025
New Workflow Streamlines Protein Structural Analysis and Supports the Growing Role of AI in Drug Discovery GenNext® Technologies, Inc., a pioneer in p...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225